MGZ Medizinisch Genetisches Zentrum

Distal Hereditary Motor Neuropathies, dHMN - HSPB8, HSBP3, GARS, DCTN1, SETX, BSCL2 (exon 3)

Klinische Symptomatik

Distal Hereditary Motor Neuropathies (dHMN) with degeneration of the second motor neuron are grouped with neuropathies. Due to the localization of the process, they are also referred to as the spinal form of Charcot-Marie-Tooth Syndrome. Congruent with the isolated affliction of the second motor neuron, affected patients normally show only distally localized motor loss.
dHMN Type 2 begins with paresis in the 20th to 40th year of life; type 5 manifests itself predominantly in the upper extremities.
ALS associated forms have also been described; dHMN caused by mutations in the SETX (Senataxin) gene are also referred to as ALS4 or juvenile ALS.
dHMN7B is caused by mutations in the DCTN1 gene (Dynactin 1); the symptoms are similar to ALS1. This HMN is often accompanied by vocal cord paresis.

Genetik

Distal hereditary motor neuropathies follow an autosomal dominant pattern of inheritance. The cause of the disease has been attributed to mutations in the HSPB8 (12q24), GARS (7p15), DCTN1 (2p13), SETX (9q34) and BSCL2 (Seipin, 11q13) genes. A spinocerebellar ataxia caused by mutations in the SETX gene (SCAR1; Ataxia Oculomotor Apraxie 2, AOA2) is an autosomal recessive inheritance; juvenile ALS4, however, is autosomal dominant.

Häufigkeit

Rare

 

Diagnostik

 

Indikation

The abovementioned dHMN symptoms, especially in combination with a positive family anamnesis.

Methodik

Point mutation analysis of all coding exons in the HSPB8, GARS, DCTN1, SETX and BSCL2 genes as well as their flanking regions using DNA sequencing.

Material

2 - 4 ml of EDTA blood

Dauer

4 - 6 weeks

Versand

Mail or courier

Beratung

For genetic counselling please call ++49-89-3090 886-0





MGZ
Medizinisch Genetisches Zentrum

Bayerstraße 3-5 (durch die Mathäser-Passage)

Eingang Schlosserstraße 6
80335 München
info@mgz-muenchen.de
Tel. +49 (0)89/30 90 886-0
Fax +49 (0)89/30 90 886-66

Ärztliche Leitung
Prof. Dr. med. Dipl. chem. Elke Holinski-Feder